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AdenosineAdenosine 5′-triphosphate (ATP) released during inﬂammation presents proinﬂammatory properties.
Adenosine, produced by catabolism of ATP, is an anti-inﬂammatory compound. Considering the role of ATP
and adenosine in inﬂammation and the importance of ectonucleotidases in themaintenance of their extracellular
levels, we investigated the effect of a selective agonist of the adenosine A2A receptor (CGS-21680) on
ectonucleotidase activities and geneexpression patterns in lymphocytes frommice submitted to anendotoxemia
model. Animals were injected intraperitoneally with 12 mg/kg Lipopolyssacharide (LPS) and/or 0.5 mg/kg CGS-
21680 or saline. Nucleotidase activities were determined in lymphocytes from mesenteric lymph nodes and
analysis of ectonucleotidase expressionwas carried out by a semi-quantitative reverse transcriptase-polymerase
chain reaction (RT-PCR) assay. Exposure to endotoxemia promoted an increase in nucleotide hydrolysis. When
CGS-21680 was administered concomitantly with LPS, this increase was prevented for ATP, adenosine 5′-
monophosphate (AMP), andp-Nitrophenyl thymidine5′-monophosphate (p-Nph-5′-TMP)hydrolysis.However,
when CGS-21680 was administered 24 h after LPS injection, the increase was not reversed. The expression
pattern of ectonucleotidases was not altered between LPS and LPS plus CGS-21680 groups, indicating that the
transcriptional control was not involved on the effect exerted for CGS-21680. These results showed an
enhancement of extracellular nucleotide catabolism in lymphocytes after induction of endotoxemia, which was
prevented, but not reversed by CGS-21680 administration. These ﬁndings suggest that the control of nucleotide
and nucleoside levels exerted by CGS-21680 could contribute to the modulation of the inﬂammatory process
promoted by adenosine A2A agonists.sicofarmacologia,Departamento
ntifícia Universidade Católica do
29, 90619-900, Porto Alegre, RS,
vier OA license.© 2010 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Inﬂammation is a defense response devised to protect the integrity
of the organism against endogenous or exogenous noxious agents
(Medzhitov, 2008). The inﬂammatory response comprises vascular
and cellular reactions ﬁnely tuned by several mediators, such as
chemical factors derived from plasma proteins or cells. Lipopolysac-
charide (LPS), a component of the outer membrane of Gram-negative
bacteria, is a molecule that triggers innate immunity and plays an
adjuvant effect on adaptive immunity (Condie et al., 1968).The role of purinergic signaling in the regulation of immune and
inﬂammatory responses has become evident. An increase in ATP release
during inﬂammation has been described and this compound presents
proinﬂammatory properties (Bodin and Burnstock, 1998). Adenosine is
a nucleoside formed by the enzymatic breakdown of ATP that acts as
neuromodulator in the central and peripheral nervous system. It has
been reported that tissue damage and inﬂammation are accompanied
by accumulation of extracellular adenosine due to its release from non-
immune and immune cells (Sitkovsky, 2003). Adenosine interacts with
four different G-protein-coupled receptors: A1, A2A, A2B, and A3
(Fredholm et al., 2001). Because this nucleoside presents anti-
inﬂammatory properties, acting mainly on adenosine A2A receptors, a
role of adenosine in the control of inﬂammation has been suggested
(Sullivan, 2003; Thiel et al., 2003; Capecchi et al., 2006). Furthermore, it
has been proposed that the administration of adenosine A2A agonists
could be useful in inﬂammatory events and sepsis (Thiel et al., 2003;
Sullivan et al., 2004).
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of immune and non-immune cells, which also co-express ATP and
adenosine receptors, is essential for the ﬁne-tuning regulation of the
duration and magnitude of purinergic signaling. Several enzyme
families are involved in the control of nucleotide andnucleoside levels:
the ecto-nucleoside triphosphate diphosphohydrolases (E-NTPDase),
the ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP)
and the ecto-5′-nucleotidase (EC 3.1.3.5) (Zimmermann, 2001).
E-NTPDases have an important role in cell adhesion and in controlling
lymphocyte function, including antigen recognition and/or the
effector activation of cytotoxic T cells (Dombrowski et al., 1995;
Dombrowski et al., 1998). Four members (E-NTPDase1-3 and 8) are
tightly bound to the plasma membrane via two transmembrane
domains, and have a large extracellular region with an active site
facing the extracellular milieu. E-NPPs have multiple physiological
roles, including nucleotide recycling, modulation of purinergic
receptor signaling, regulation of extracellular pyrophosphate levels,
stimulation of cell motility, and possible roles in the regulation of
insulin receptor signaling and the activity of ecto-kinases (Goding
et al., 2003). Ecto-5′-nucleotidase (CD73) is a lymphocyte maturation
marker, which is involved in intracellular signaling, lymphocyte
proliferation and activation (Airas, 1998; Resta et al., 1998).
Considering the roles that the nucleotides and nucleosides play
during inﬂammatory events, and the importance of ectonucleotidases
for the maintenance of extracellular levels of the former, we inves-
tigated the effect of a selective agonist of the adenosine A2A receptor
(CGS-21680) on ectonucleotidase activities in lymphocytes frommice
submitted to an endotoxemia model. Furthermore, the effect of LPS
and CGS-21680 on the E-NTPDase, E-NPP, and ecto-5′-nucleotidase
gene expression were also evaluated in mesenteric lymph nodes.
2. Materials and methods
2.1. Chemicals
CGS-21680 hydrochloride (3-[4-[2-[[6-amino-9-[(2R,3R,4S,5S)-5-
(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]purin-2-yl]amino]ethyl]
phenyl]propanoic acid), HEPES (2-[4-(2-hydroxyethyl)piperazin-1-yl]
ethanesulfonic acid), Lipopolysaccharide (LPS) from Escherichia coli,
serotype 0111:B4, nucleotides (ATP, ADP, and AMP), Malachite
Green, Trizma Base, and p-Nitrophenyl thymidine 5′-monophosphate
(p-Nph-5′-TMP) were obtained from Sigma-Aldrich (St. Louis, MO,
USA). The RNASpin Ilustra Mini Kit for RNA isolation was purchased
fromGEHealthcare. dNTPs, oligonucleotides, Taq polymerase, LowDNA
Mass Ladder, and SuperScript™ III First-Strand Synthesis SuperMix
were purchased from Invitrogen (Carlsbad, CA, USA). Primers were
obtained from Integrated DNA Technologies (Coralville, IA, USA) and
GelRed™ was purchased from Biotium (Hayward, CA, USA). The LDH
LiquiformKitwas purchased from Labtest Diagnóstica S.A. (Lagoa Santa,
MG, Brazil). All reagents were of analytical grade.
2.2. Animals
In all experiments, male F1 mice (approximately 8–10 weeks old,
weighing around 50 g) from Fundação Estadual de Produção e
Pesquisa em Saúde (FEPPS, Porto Alegre, RS, Brazil) were used and
housed four to a cage, with water and food ad libitum. The animal
house was kept on a 12 h light/dark cycle (lights on at 7:00 am) at a
temperature of 23±1 °C. Procedures for the care and use of animals
were adopted according to the regulations of the Colégio Brasileiro de
Experimentação Animal (COBEA), based on the Guide for the Care and
Use of Laboratory Animals (National Research Council) and all efforts
were made to minimize the number of animals used in this study and
their suffering. This study was approved by the Ethics Committee of
Universidade Federal do Rio Grande do Sul (UFRGS) under license
number 2006628.2.3. Experimental protocols
The animals received intraperitoneal (i.p.) injections of saline
(0.9%), LPS (12 mg/kg) (Pawlinski et al., 2003), and CGS-21680
(0.5 mg/kg body weight) (Martire et al., 2007), according to the
groups described below. All solutions were administered in a volume
of 2 μl/kg body weight. Mice were randomly divided in: (i) control
group (SAL), which received a single saline injection, (ii) CGS group
(CGS), which received a single injection of CGS-21680, (iii) LPS group
(LPS 24 h), which was submitted to the endotoxemia model by a
single injection of LPS, and (iv) LPS+CGS (LPS+CGS 24 h), which
was submitted to the endotoxemia model by a single injection of LPS
and received a single injection of CGS-21680 immediately after. In
order to evaluate the effect of CGS-21680 when the endotoxemia had
already become established, the following groups were analyzed:
(v) LPS group (LPS 48 h), which was submitted to the endotoxemia
model by a single injection of LPS and 24 h later received a single
injection of saline, and (vi) LPS+CGS (LPS+CGS 48 h), which was
submitted to the endotoxemia model by a single injection of LPS and
24 h later received a single injection of CGS-21680. All animals were
euthanized by decapitation 24 h after the last injection.
2.4. Isolation of lymphocytes
Mesenteric lymph nodes were removed and passed through a
mesh grid in wash buffer (the same buffer used in the enzyme assays,
without divalent cations). Cells were washed two times with this
buffer by centrifugation at 200 g for 10 min. After, the cells were
stained with 0.1% Trypan Blue and counted, and only the groups with
more than 95% viability were used in the experiments.
2.5. Assays of ecto-nucleoside triphosphate diphosphohydrolase
(E-NTPDase) and ecto-5′-nucleotidase activities
The reaction medium contained 1 mM CaCl2 (for ATP and ADP
hydrolysis) or MgCl2 (for AMP hydrolysis), 120 mM NaCl, 5 mM KCl,
60 mM glucose, 1 mM sodium azide, 0.1% mM albumin, and 20 mM
Hepes buffer, pH 7.5, in a ﬁnal volume of 200 μl. Approximately 108
lymphocytes were added to the reaction medium and the enzyme
reaction was started by the addition of ATP, ADP or AMP to a ﬁnal
concentration of 2 mM, followed by incubation for 30 min at 37 °C.
The reaction was stopped with 200 μl of 10% trichloroacetic acid
(TCA). Incubation times, protein concentrations, reaction mixtures,
and substrate concentration were chosen and modiﬁed according to a
study previously published by Vuaden et al. (2007). The amount of
inorganic phosphate (Pi) released was measured using a colorimetric
method as previously outlined by Chan et al. (1986). Controls to
correct for non-enzymatic substrate hydrolysis were performed by
adding the cells after the reactions had been stopped with TCA. All
reactions were performed in triplicate. Enzyme activities were
generally expressed as nmol Pi released per min per 108 cells.
2.6. Assay of ecto-nucleotide pyrophosphatase/phosphodiesterase
(E-NPP) activity
The phosphodiesterase activity was assessed using ρ-Nph-5′-TMP
(an artiﬁcial substrate). The reaction medium contained 1 mM CaCl2,
120 mM NaCl, 5 mM KCl, 60 mM glucose, 1 mM sodium azide, 0.1%
mM albumin, and 20 mM Tris buffer, pH 8.9, in a ﬁnal volume of
200 μl. Approximately 108 lymphocytes were added to the reaction
medium and the enzyme reaction was started by the addition of
ρ-Nph-5′-TMP to a ﬁnal concentration of 0.5 mM. After 60 min of
incubation, 200 μl of 0.2 N NaOH were added to the medium to stop
the reaction. Incubation time and protein concentration were
chosen in order to ensure the linearity of the reaction. The amount
of ρ-nitrophenol released from the substrate wasmeasured at 400 nm
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correct for non-enzymatic substrate hydrolysis were performed by
adding the cells after the reaction had been stopped with NaOH.
All reactions were performed in triplicate. Enzyme activity was
generally expressed as nmol ρ-nitrophenol released per min per 108
cells (Sakura et al., 1998; Vuaden et al., 2009).2.7. Analysis of gene expression by semi-quantitative RT-PCR
Analysis of NTPDase1 (Entpd1), 2 (Entpd2), 3 (Entpd3),
8 (Entpd8), NPP1 (Enpp1), 2 (Enpp2), 3 (Enpp3), and 5′-nucleotidase
(Nt5e) gene expression was carried out by a semi-quantitative
reverse transcriptase-polymerase chain reaction (RT-PCR) assay.
Twenty-four and/or 48 h after treatments, mesenteric lymph nodes
of mice (n=3 for each group) were removed for total RNA extraction
with the RNASpin Ilustra Mini Kit in accordance with the manufac-
turer's instructions. RNA purity was quantiﬁed spectrophotometri-
cally and assessed by electrophoresis in a 1.0% agarose gel using
GelRed™. The cDNA species were synthesized using SuperScript™ III
First-Strand Synthesis SuperMix from 3 μg of total RNA following the
supplier's instructions. For PCR assays, 1 μl of cDNA was used as a
template and screenedwith speciﬁc primers for Entpd1, 2, 3, 8, Enpp1,
2, 3 and Nt5e. PCR reactions were carried out in a volume of 25 μl
using a concentration of 0.2 μMof each primer, 200 μMMgCl2, and 1 U
Taq polymerase. The cycling conditions for all PCRs were as follows:
Initial 1 min denaturation step at 94 °C, 1 min at 94 °C, 1 min
annealing step (Entpd1, 2, Enpp1 and Actb: 63 °C; Entpd3, Enpp3
and Nt5e: 62 °C; Entpd8: 64 °C; Enpp: 61 °C), 1 min extension step at
72 °C. These steps were repeated for 35 cycles. Finally, a 10 min post-
extension step was performed at 72 °C. Primer sequences as well as
the ampliﬁcation products are listed in Table 1. Ten microliters of the
PCR reaction mixture were analyzed on a 1% agarose gel using
GelRed™ and photographed under UV light. The Low DNA Mass
Ladder was used as a molecular marker and normalization was
performed employing Actb (β-actin) as a constitutive gene. The
images of stained PCR products were analyzed by optical densito-
metry and semi-quantiﬁed (enzyme/Actb mRNA ratios) using the
computer software Image J.2.8. Statistical analysis
Results are expressed as means±standard error (S.E.M.). Statis-
tical analysis was performed by one-way analysis of variance
(ANOVA), followed by a Tukey multiple range test. Statistically
signiﬁcant differences between groups were considered for a Pb0.05.Table 1
PCR primers sequences.
Enzyme Sequence (5′-3′)
Entpd1 Sense GGT GGC GTC CTT AAG GAC CCG TGC
Entpd1 Antisense GGA GCT GTC TGT GAA GTT ATA GCC TTG CAG
Entpd2 Sense CCA CTG TCA GCC TGT CAG GGA CCA GC
Entpd2 Antisense CGA CAG CCG TGT CTG CCG CCT TC
Entpd3 Sense ACC GCC TTC ACC TTG GGC CAT G
Entpd3 Antisense GCT GAG AAG CAG TAG GAC CGG GCA TAC
Enpp1 Sense TAT TGG CTA TGG ACC TGC CTT CAA GC
Enpp1 Antisense GTA GAA TCC GGG GCC TCC CGT AG
Enpp2 Sense GCG ATC TCC TAG GCT TGA AGC CAG C
Enpp2 Antisense GCT CTG GGA TGC TAG AGA CCT CAG CCT G
Enpp3 Sense ACA TGC AGG AGA GTT GTC AAC CCC TGC
Enpp3 Antisense AGA ACA GTG TAT GAA CTC CAC ATG GGC ATC
Nt5e Sense CCA TCA CCT GGG AGA ACC TGG CTG C
Nt5e Antisense CTT GAT CCG CCC TTC AAC GGC TG
Actb Sense GTG CTA TGT TGC TCT AGA CTT CGA GCA GG
Actb Antisense CAC CGA TCC ACA CAG AGT ACT TGC GCT C3. Results
3.1. Cellular integrity
The lymphocyte preparation integrity was checked by measuring
lymphocyte lactate dehydrogenase (LDH) activity. The ratio of this
enzyme activity measured in intact and disrupted lymphocytes can be
regarded as a measure of damaged particles. The protocol was carried
out according to the manufacturer's instructions. Triton X-100 (1%,
ﬁnal concentration) was used to disrupt the lymphocyte preparation.
The measurement of LDH activity showed that most cells (approxi-
mately 90%, n=3) were intact after the isolation procedure (data not
shown).3.2. Effect of LPS-induced endotoxemia model and CGS-21680 on
ectonucleotidase activities in lymphocytes
After 24 h of LPS exposure we observed a signiﬁcant increase in
ATP hydrolysis (178%) when compared with the control group. This
increase was prevented when CGS-21680 was co-administered with
LPS. Likewise, after 48 h of LPS exposure, we observed a signiﬁcant
increase in ATP hydrolysis (135%) when compared with control,
although this was not reversed by the administration of CGS-21680
(Fig. 1A). Fig. 1B shows that when compared to control ADP hydrolysis
increased signiﬁcantly after induction of endotoxemia with LPS.
However, there was no signiﬁcant difference between groups that
received LPS plus CGS-21680 and the groups that received LPS only.Fig. 1. ATP (A) and ADP (B) hydrolysis in lymphocytes frommesenteric lymph nodes of
mice 24 and 48 h after endotoxemia induction and CGS-21680 treatment. The data
represent mean±S.E.M. (n=5 at least). Statistical analyses were performed by one-
way analysis of variance (ANOVA), followed by a Tukeymultiple range test, considering
Pb0.05 as signiﬁcant (*). Mice were divided in: (i) control group (SAL), which received
a single saline injection, (ii) CGS group (CGS), which received a single injection of CGS-
21680, (iii) LPS group (LPS 24 h), which was submitted to a single injection of LPS,
(iv) LPS+CGS (LPS+CGS 24 h), which was submitted to a single injection of LPS and
received a single injection of CGS-21680 immediately after, (v) LPS group (LPS 48 h),
which was submitted to a single injection of LPS and 24 h later received a single
injection of saline, and (vi) LPS+CGS (LPS+CGS 48 h), which was submitted to a
single injection of LPS and 24 h later received a single injection of CGS-21680.
Fig. 3. AMP hydrolysis (A) in lymphocytes frommesenteric lymph nodes of mice 24 and
48 h after endotoxemia induction and CGS-21680 treatment. The data represent a
mean±S.E.M. (n=5 at least). Statistical analyses were performed by one-way analysis
of variance (ANOVA), followed by a Tukey multiple range test, considering Pb0.05 as
signiﬁcant (*). Mice were divided in: (i) control group (SAL), which received a single
saline injection, (ii) CGS group (CGS), which received a single injection of CGS-21680,
(iii) LPS group (LPS 24 h), which was submitted to a single injection of LPS, (iv) LPS+
CGS (LPS+CGS 24 h), which was submitted to a single injection of LPS and received a
single injection of CGS-21680 immediately after, (v) LPS group (LPS 48 h), which was
submitted to a single injection of LPS and 24 h later received a single injection of saline,
and (vi) LPS+CGS (LPS+CGS 48 h), which was submitted to a single injection of LPS
and 24 h later received a single injection of CGS-21680.
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determine phosphodiesterase activities, was signiﬁcantly increased
after 24 h of LPS treatment when compared to control (117%). This
increase was prevented by the co-administration of CGS-21680. After
48 h of LPS injection, therewas a signiﬁcant increase (147%) in ρ-Nph-
5′-TMP hydrolysis when compared to saline-treated controls (Fig. 2)
and this increase persisted after CGS-21680 administration. For
AMP hydrolysis we observed a signiﬁcant increase after 24 h of
LPS exposure (180%) when compared to the control group and the
hydrolysis of this nucleotide was similar to control group after co-
administration of LPS plus CGS-21680. After 48 h of LPS treatment,
we veriﬁed a signiﬁcant increase in AMP hydrolysis (105%), and the
CGS-21680 administration did not reverse this effect (Fig. 3).
3.3. Effect of LPS and CGS-21680 on ectonucleotidase mRNA expression
in mesenteric lymph nodes
The results show that mRNA transcript levels were altered in after
LPS and LPS plus CGS-21680 treatments when compared to saline
group for Entpd3 and Enpp3 (Fig. 4A and B). For others enzymemRNA
transcripts we did not observe signiﬁcant alterations in mesenteric
lymph nodes after the treatments (data not shown).We examined the
Entpd8 transcripts in liver (as a positive control) and in mesenteric
lymph nodes. However, we found that Entpd8 was not expressed in
lymph nodes (data not shown).
4. Discussion
In the present study, we observed that LPS-induced endotoxemia
model increased the nucleotide hydrolysis promoted by E-NTPDases,
E-NPP and ecto-5′-nucleotidase activities in lymphocytes of mice. In
addition, the co-administration of CGS-21680 with LPS was able to
prevent the increase of enzyme activities.
A role for the purinergic system in the immune response has
become more accepted over the last few years. In a brief update, Di
Virgilio (2007) reported that interest in this hypothesis is slowly
growing among the immunological community, as observed by the
increase in the number of papers reporting the effect of purinergic
agonists on many different immune-mediated responses. It has been
demonstrated that extracellular ATP is accumulated at sites ofFig. 2. ρ-Nph-5′-TMP hydrolysis (A) in lymphocytes from mesenteric lymph nodes of
mice 24 and 48 h after endotoxemia induction and CGS-21680 treatment. The data
represent a mean±S.E.M. (n=5 at least). Statistical analyses were performed by one-
way analysis of variance (ANOVA), followed by a Tukeymultiple range test, considering
Pb0.05 as signiﬁcant (*). Mice were divided in: (i) control group (SAL), which received
a single saline injection, (ii) CGS group (CGS), which received a single injection of CGS-
21680, (iii) LPS group (LPS 24 h), which was submitted to a single injection of LPS,
(iv) LPS+CGS (LPS+CGS 24 h), which was submitted to a single injection of LPS and
received a single injection of CGS-21680 immediately after, (v) LPS group (LPS 48 h),
which was submitted to a single injection of LPS and 24 h later received a single
injection of saline, and (vi) LPS+CGS (LPS+CGS 48 h), which was submitted to a
single injection of LPS and 24 h later received a single injection of CGS-21680.inﬂammation and induces an inﬂammatory response, being, in
relevant amounts, considered a signal of tissue injury or distress (Di
Virgilio et al., 2009). Other work has shown that ATP acts as an
immunomodulatory agent via P2X and P2Y receptors, more speciﬁ-
cally via the P2X7 subtype (Ferrari et al., 2006). In addition, adenosine,
the ﬁnal product of ATP hydrolysis, exerts anti-inﬂammatory effects
via A2A receptors (Di Virgilio et al., 2009).Fig. 4. Gene expression patterns of Entpd3, Enpp3, and Actb in mesenteric lymph nodes
of mice. Total RNA was isolated and subjected to RT-PCR for the indicated targets. Three
independent experiments were performed, with entirely consistent results. Mice were
divided in: (i) control group (SAL), which received a single saline injection, (ii) CGS
group (CGS), which received a single injection of CGS-21680, (iii) LPS group (LPS 24 h),
which was submitted to a single injection of LPS, (iv) LPS+CGS (LPS+CGS 24 h),
which was submitted to a single injection of LPS and received a single injection of CGS-
21680 immediately after, (v) LPS group (LPS 48 h), which was submitted to a single
injection of LPS and 24 h later received a single injection of saline, and (vi) LPS+CGS
(LPS+CGS 48 h), which was submitted to a single injection of LPS and 24 h later
received a single injection of CGS-21680.
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cleotidases (NTPDase family, NPP family and ecto-5′-nucleotidase)
(Zimmermann, 2001). Besides their involvement in the role of ATP in
inﬂammation, enzymes that degrade extracellular nucleotides, such
as NTPDase1 (CD39) and 5′-nucleotidase (CD73), present immuno-
modulatory activity (Dwyer et al., 2007). Furthermore, NTPDases
play an important role in lymphocyte function, since extracellular
nucleotides are mediators of immune and non-immune cell function
(Dombrowski et al., 1998).
Our results demonstrated a signiﬁcant increase in nucleotide
hydrolysis in lymphocytes after mice had been exposed to endotox-
emia model, both at 24 h and 48 h after LPS exposure. A similar result
was observed previously in our laboratory, when rats were injected
with LPS and the hydrolysis of ATP, ADP, and AMP in lymphocytes
from mesenteric lymph nodes was determined later (Vuaden et al.,
2007). This increase in nucleotide hydrolysis could be related to a
compensatory response, decreasing the availability of ATP, a proin-
ﬂammatory agent, and, consequently, contributing to the production
of extracellular adenosine, an anti-inﬂammatory compound. Here
we investigated the effect of CGS-21680, a selective A2A adenosine
receptor agonist, on nucleotide catabolism. When CGS-21680
was administered alone, we did not observe a signiﬁcant difference
compared to the control group. However, when CGS-21680 was
administered concomitantly with LPS, it was able to prevent the LPS-
induced increase in ATP, AMP, and ρ-Nph-5′-TMP hydrolysis (LPS+
CGS 24 h group). In contrast, when CGS-21680 was administered 24 h
after LPS injection, the increase was not reversed (LPS+CGS 48 h
group). Therefore, we suggest that this selective A2A agonist can
prevent the endotoxemic effects of LPS, but cannot reverse such
effects when the endotoxemia model has already been established.
Despite the effects observed on ATP hydrolysis, there was no
signiﬁcant difference between LPS and LPS plus GCS-21680 groups
for ADP hydrolysis. Since it has been reported that E-NTPDases
present different abilities to hydrolyze tri and diphosphonucleosides
(Zimmermann, 2001), we cannot exclude the possibility that LPS
might up-regulate the ectonucleotidase activities and that the co-
administration of CGS-21680 could prevent the LPS-induced effect
over distinct E-NTPDase members.
In order to evaluate whether the endotoxemia model and CGS-
21680 could alter the ectonucleotidase gene expression, we per-
formed RT-PCR assays. The gene expression pattern of ectonucleoti-
dases presented an increase inmRNA levels in groups treatedwith LPS
and LPS plus CGS-21680 mainly for Entpd3 and Enpp3. For other
enzyme mRNA transcript levels analyzed, the differences between
treated groups and control group were not so evident. Interestingly,
these results differ from the rat model of endotoxemia in which we
previously demonstrated that LPS decreased the Entpd and Nt5e
mRNA levels from rat lymph nodes (Vuaden et al., 2007). Although
LPS also induced an increase on ectonucleotidase activities from rat
lymphocytes, the regulation of gene expression is dependent of
various aspects involving cell machinery and transduction signaling
pathways. Since enzyme activity cannot be directly correlated to gene
expression pattern or to protein levels due to the existence of several
post-translational events (Nedeljkovic et al., 2005), these apparently
discrepancies between rat and mice gene expression proﬁle in the
LPS-induced endotoxemia model still require further investigations.
Adenosine receptors are coupled to G-proteins, and adenosine A2A
and A2B receptors in particular can increase intracellular cAMP levels
by activating adenylate cyclase. The expression pattern of adenosine
receptor subtypes (A1, A2A, A2B, and A3) varies depending on the cell
type and pharmacological and biochemical studies have established
that A2A receptor is the predominant subtype in immune cells (Huang
et al., 1997; Koshiba et al., 1999). The anti-inﬂammatory effects
of extracellular adenosine mediated through adenosine receptor
signaling have been known and investigated for a long time
(Fredholm et al., 2001). Numerous studies in cellular and animalmodel systems have provided evidence that A2A signaling pathways
are active in limiting inﬂammation and tissue injury (Hasko and
Cronstein, 2004; Linden, 2005; Sitkovsky and Ohta, 2005; Hasko and
Pacher, 2008). The interaction between adenosine and A2A receptors
is capable of inhibiting inﬂammation by cAMP induction (Ohta and
Sitkovsky, 2009). Experimental data suggest that A2A agonists and
antagonists can mediate inﬂammation by activating and blocking,
respectively, an A2A-dependent immunomodulatory mechanism
(Ohta and Sitkovsky, 2001). A2A receptors has numerous anti-
inﬂammatory properties, as well as inhibiting T-cell activation
(Huang et al., 1997; Erdmann et al., 2005) and limiting the production
of inﬂammatory mediators, such as IL-12, TNF-α· and INFγ (Hasko
et al., 2000; Pinhal-Enﬁeld et al., 2003; Lappas et al., 2005).
It is important mention that there are some limitations in the
current study. Firstly, we have performed these experiments using a
single dose of one adenosine A2A agonist. Studies have already
shown that other agonists of A2A adenosine receptors present anti-
inﬂammatory actions, such as ATL146e, ATL313, and IB-MECA
(Sullivan et al., 2004; Odashima et al., 2005; Lappas et al., 2006;
Sevigny et al., 2007). However, few and recent studies have
demonstrated that CGS-21680 is able to protect or revert inﬂamma-
tory states (Lappas et al., 2005; Genovese et al., 2009; Kreckler et al.,
2009). The choice of this CGS-21680 dose, which was administered i.
p., was base on previous studies indicating its ability to activate
adenosine A2A receptor (Martire et al., 2007). We have chosen to test
CGS-21680 in two different times of LPS exposures in order to
evaluate potential actions of this compound on purine catabolism in
modeled endotoxemia. Therefore, testing different CGS-21680 doses
and adenosine A2A agonists would reinforce the idea that activation of
adenosine A2A receptors may exert a modulatory role in the
inﬂammatory responses. Furthermore, other adenosine A2A antago-
nists, such as caffeine or ZM241385, can be tested in order to evaluate
a possible increase in the severity of the inﬂammatory state after
modeled endotoxemia. We consider that our ﬁndings may support
future studies aiming the use of different doses of CGS-21680 and
different adenosine agonists as anti-inﬂammatory compounds.
A study performed by Deaglio et al. (2007) provided new
information about the mechanism of adenosine generation and
immunoregulation by Tregs cells. They demonstrated that Tregs
cells express a unique combination of both CD39 (E-NTPDase1) and
CD73 (ecto-5′-nucleotidase). These ﬁndings demonstrate that the
production of adenosine through the enzymatic cascade on the
surface of Tregs is important to the A2A-mediated immunosuppressive
effects of these cells (Deaglio et al., 2007). These results provide an
example of how the coordinate regulation of adenosine production
and signaling can impact the immune response. Here we demonstrate
that the nucleotide hydrolysis was increased when endotoxemia
model was induced in mice. We hypothesized that this increase in
ectonucleotidase activities promoted by LPS is a response against
the inﬂammatory process, resulting in ATP depletion and adenosine
generation. The effect of LPS on ectonucleotidase activities was
prevented when LPS was co-administered with CGS-21680. However,
when LPS was administered 24 h before CGS-21680, this compound
failed to reverse the effect of LPS. Probably, in the initial phase, when
LPS not exert all of inﬂammatory effects yet, the selective A2A receptor
agonist was able to prevent the ectonucleotidase stimulation. In
contrast, when the LPS-induced inﬂammatory process has been
already established and the production of adenosine has been
enhanced, CGS-21680 was not effective to reverse ectonucleotidase
activities to control levels.
5. Conclusion
In summary, our results demonstrate an enhancement of extra-
cellular nucleotide catabolism in lymphocytes after the induction of
the modeled endotoxemia, which was prevented, but not reversed by
217F.C. Vuaden et al. / European Journal of Pharmacology 651 (2011) 212–217CGS-21680 administration. These data suggest that the protective
effect of CGS-21680 on the LPS-induced alterations in the ectonu-
cleotidase activities could be related, at least in part, to the effects
promoted by the A2A receptor agonists during inﬂammation.
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